Drug Type Small molecule drug |
Synonyms Compound Reserpine and Hydrochlorthiazide, 氢氟噻嗪/利血平, SALUTENSIN-DEMI + [1] |
Target |
Mechanism NCC inhibitors(Thiazide-sensitive sodium-chloride cotransporter inhibitors), VMAT2 inhibitors(Synaptic vesicular amine transporter inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (20 Jun 1960) |
Regulation- |
Molecular FormulaC8H8F3N3O4S2 |
InChIKeyDMDGGSIALPNSEE-UHFFFAOYSA-N |
CAS Registry135-09-1 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | CN | 01 Jan 1982 |